Page last updated: 2024-12-05

1-methyluracil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-Methyluracil is a naturally occurring compound found in various organisms, including bacteria, fungi, and mammals. It is a methylated derivative of uracil, a key component of RNA. 1-methyluracil plays a role in DNA repair mechanisms and has been implicated in various biological processes, including immune response and cellular signaling. Notably, it is also a significant component of the antibiotic 5-fluorouracil (5-FU), a widely used chemotherapy drug. The synthesis of 1-methyluracil can be achieved through various methods, including chemical methylation of uracil and enzymatic methylation using specific methyltransferases. Research into 1-methyluracil focuses on understanding its biological roles, potential therapeutic applications, and its contribution to various diseases. '

1-methyluracil: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1-methyluracil : A pyrimidone that is uracil with a methyl group substituent at position 1. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12009
CHEMBL ID4797970
CHEBI ID69445
SCHEMBL ID35355
SCHEMBL ID12677264
MeSH IDM0043267

Synonyms (46)

Synonym
4zb2484q0m ,
unii-4zb2484q0m
nsc 44432
EN300-23560
1-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
nsc-44432
nsc44432
uracil, 1-methyl-
615-77-0
2,3h)-pyrimidinedione, 1-methyl-
1-methyluracil
1-methylpyrimidine-2,4-dione
2,4(1h,3h)-pyrimidinedione, 1-methyl-
1-methylpyrimidine-2,4(1h,3h)-dione
inchi=1/c5h6n2o2/c1-7-3-2-4(8)6-5(7)9/h2-3h,1h3,(h,6,8,9
1-methyluracil, 99%
AKOS001204335
1-methyl-2,4(1h,3h)-pyrimidinedione
HMS1741M02
A833314
CHEBI:69445
GEO-01979
FT-0608099
SCHEMBL35355
1-methyl-1h-pyrimidine-2,4-dione
F2185-0048
W-200459
SCHEMBL12677264
1-methyl-2,4(1h,3h)-pyrimidinedione #
DTXSID90210474
mfcd00038666
AT19346
STL511064
BCP07466
Q27137782
1-methyl-1h,3h-pyrimidine-2,4-dione
n1-methyluracil
AMY15029
BBL100079
SB57615
BS-22717
bdbm50549810
chembl4797970 ,
CS-W011165
SY056678
Z154666196
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
pyrimidoneA pyrimidine carrying one or more oxo substituents.
nucleobase analogueA molecule that can substitute for a normal nucleobase in nucleic acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Protein cereblonHomo sapiens (human)IC50 (µMol)65.70000.28601.70663.0000AID1685005
Protein cereblonHomo sapiens (human)Ki30.80001.49006.580010.0000AID1685005
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (7)

Processvia Protein(s)Taxonomy
protein ubiquitinationProtein cereblonHomo sapiens (human)
positive regulation of Wnt signaling pathwayProtein cereblonHomo sapiens (human)
negative regulation of protein-containing complex assemblyProtein cereblonHomo sapiens (human)
positive regulation of protein-containing complex assemblyProtein cereblonHomo sapiens (human)
negative regulation of monoatomic ion transmembrane transportProtein cereblonHomo sapiens (human)
locomotory exploration behaviorProtein cereblonHomo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processProtein cereblonHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
protein bindingProtein cereblonHomo sapiens (human)
transmembrane transporter bindingProtein cereblonHomo sapiens (human)
metal ion bindingProtein cereblonHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
nucleusProtein cereblonHomo sapiens (human)
cytoplasmProtein cereblonHomo sapiens (human)
cytosolProtein cereblonHomo sapiens (human)
membraneProtein cereblonHomo sapiens (human)
perinuclear region of cytoplasmProtein cereblonHomo sapiens (human)
Cul4A-RING E3 ubiquitin ligase complexProtein cereblonHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1685005Binding affinity to human CRBN-thalidomide binding domain expressed in Escherichia coli by measuring baseline corrected normalized fluorescence by MST based assay2021ACS medicinal chemistry letters, Jan-14, Volume: 12, Issue:1
Sweet and Blind Spots in E3 Ligase Ligand Space Revealed by a Thermophoresis-Based Assay.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (20.83)18.7374
1990's6 (25.00)18.2507
2000's7 (29.17)29.6817
2010's4 (16.67)24.3611
2020's2 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.99 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]